These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11383981)

  • 1. The mechanism of lithium action: state of the art, ten years later.
    Shaldubina A; Agam G; Belmaker RH
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):855-66. PubMed ID: 11383981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IP3 accumulation and/or inositol depletion: two downstream lithium's effects that may mediate its behavioral and cellular changes.
    Sade Y; Toker L; Kara NZ; Einat H; Rapoport S; Moechars D; Berry GT; Bersudsky Y; Agam G
    Transl Psychiatry; 2016 Dec; 6(12):e968. PubMed ID: 27922641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
    Ikonomov OC; Manji HK
    Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common mechanism of action for three mood-stabilizing drugs.
    Williams RS; Cheng L; Mudge AW; Harwood AJ
    Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular targets of lithium action.
    Phiel CJ; Klein PS
    Annu Rev Pharmacol Toxicol; 2001; 41():789-813. PubMed ID: 11264477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium and synaptic plasticity.
    Salinas PC; Hall AC
    Bipolar Disord; 1999 Dec; 1(2):87-90. PubMed ID: 11252664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
    Manji HK; Moore GJ; Chen G
    Biol Psychiatry; 1999 Oct; 46(7):929-40. PubMed ID: 10509176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
    Einat H; Manji HK
    Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical effects of lithium on serotonergic receptor function: an immunocytochemical, behavioural and autoradiographic study.
    Moorman JM; Leslie RA
    Neuropharmacology; 1998; 37(3):357-74. PubMed ID: 9681934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is phosphoadenosine phosphate phosphatase a target of lithium's therapeutic effect?
    Shaltiel G; Deutsch J; Rapoport SI; Basselin M; Belmaker RH; Agam G
    J Neural Transm (Vienna); 2009 Nov; 116(11):1543-9. PubMed ID: 19756369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta).
    Serretti A; Drago A; De Ronchi D
    Curr Med Chem; 2009; 16(15):1917-48. PubMed ID: 19442155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton magnetic resonance spectroscopy changes after lithium treatment. Systematic review.
    Szulc A; Wiedlocha M; Waszkiewicz N; Galińska-Skok B; Marcinowicz P; Gierus J; Mosiolek A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():1-8. PubMed ID: 29414126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium neuroprotection: molecular mechanisms and clinical implications.
    Rowe MK; Chuang DM
    Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations.
    Lovestone S; Davis DR; Webster MT; Kaech S; Brion JP; Matus A; Anderton BH
    Biol Psychiatry; 1999 Apr; 45(8):995-1003. PubMed ID: 10386182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem brain from bipolar patients.
    Belmaker RH; Agam G; van Calker D; Richards MH; Kofman O
    Neuropsychopharmacology; 1998 Sep; 19(3):220-32. PubMed ID: 9653710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.
    Chen G; Huang LD; Jiang YM; Manji HK
    J Neurochem; 1999 Mar; 72(3):1327-30. PubMed ID: 10037507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular mechanism for the effect of lithium on development.
    Klein PS; Melton DA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8455-9. PubMed ID: 8710892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents.
    Mai L; Jope RS; Li X
    J Neurochem; 2002 Jul; 82(1):75-83. PubMed ID: 12091467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.